Yale University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Yale University sits in the top decile of US sponsors by registered trial count (#13 of 15,742 sponsors by registered trial count).
Yale University: 1,492 sponsored US clinical trials, 254 recruiting.
Yale University sponsors 1,492 registered US clinical trials on ClinicalTrials.gov, 254 of them currently recruiting, and 1,005 completed. 99 of these trials are in Phase 3-4 (later-stage) and 579 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Opioid Use Disorder, with 19 trials.
Top-decile sponsor footprint
Yale University ranks in the top decile of sponsors by registered trial count (#13 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,005 of 1,138 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,492 total, page 28 of 30
A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid Cancers
NCT00337376
A Study of Everolimus in Combination With Imatinib in Metastatic Melanoma
NCT00402662
Do Treatments for Smoking Cessation Affect Alcohol Drinking? Study 1: Nicotine Replacement Therapy
NCT00699556
The Effects of Estradiol and Progesterone on Arginine Vasopressin Regulation and Serum Sodium Concentration
NCT00589134
N-acetylcysteine and NMDA Antagonist Interactions
NCT00611897
Studies on Aldosterone and Vascular Function
NCT00700479
Vascular Effects of Sertraline in Heart Failure
NCT00585455
Craving, Binge Eating and Obesity
NCT00414167
GABA Mechanisms Underlying the Vulnerability to Alcohol Dependence
NCT00611767
High-dose Periop Statins for Prevention of DVT
NCT00259662
Chemoembolization Using Doxorubicin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
NCT00293397
A Pilot Study to Determine the Safety of the Combination of Ontak in Combination With CHOP in Peripheral T-Cell Lymphoma
NCT00337987
Effects of Rosiglitazone on the Metabolic Phenotype of Impaired Glucose Tolerance in Youth
NCT00413335
Dose Escalation Study of Clofarabine in Patients With Relapsed or Refractory Low Grade or Intermediate-Grade B-Cell Lymphoma
NCT00338494
Levetiracetam in the Management of Bipolar Depression
NCT00566150
Culturally Responsive Person-Centered Care for Psychosis
NCT00231933
Effects of Recombinant Human Erythropoietin on Platelet Function in Healthy Subjects
NCT00368238
Evaluation of the Child and Family Traumatic Stress Intervention
NCT01031615
Enhancing Emergency Practitioner (EP)-Performed Alcohol Interventions in the Emergency Department (ED)
NCT00261859
Safety of Dialysate Sodium Individualization in Hemodialysis Patients With Intradialytic Hypotension
NCT00237783
Bariatric Surgery for ESRD Patients vs Control
NCT00580762
Buprenorphine and Integrated HIV Care
NCT00317460
Study of Early Hormone Replacement Therapy on Risk Factors for Sudden Cardiac Death
NCT00580775
Galantamine for Cognitive Deficits in Schizophrenia
NCT00463879
Integration of Buprenorphine Into HIV Clinical Settings - Primary Care Model (PCM)
NCT00798538
Effects of Atomoxetine on Cognitive Function in Schizophrenia
NCT00420498
FMRI of Stress and Addictive Disorders
NCT01558973
Counseling for Primary Care Office-based Buprenorphine
NCT00595764
A Double-blind Study to Determine if Intraduodenal Indomethacin Can Decrease the Incidence of Post-ERCP Pancreatitis
NCT00727740
Impact of Hypoglycemia Unawareness on Brain Metabolism Cognition in T1DM
NCT00575783
Effect of Medium Chain Fatty Acids on Cognitive Function During Acute Hypoglycemia in Patients With Type 1 Diabetes
NCT00592072
Neural, Behavioral and Physiological Correlates of Feeding in Humans
NCT01665560
Microvascular Reactivity.
NCT00259701
Project BEST: Buprenorphine Entry Into Substance Abuse Treatment
NCT02583243
CBT With Disulfiram and Contingency Management
NCT00350870
Effect of Age on Latanoprost 0.005% in Patients With Glaucoma
NCT00224289
Validation of the Gated Blood Pool SPECT: ERNA vs 3D Echo
NCT00576186
Insulin Resistance Intervention After Stroke Trial
NCT00091949
Use Ear Acupuncture as Treatment for Low Back Pain During Pregnancy
NCT00571480
Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer
NCT00104975
Effectiveness of Lofexidine to Prevent Stress-Related Opiate Relapse During Naltrexone Treatment - 1
NCT00142909
Targeted Interventions for Weight-Concerned Smokers
NCT00105482
The Effect of Protein on Calcium Absorption and Gastric Acid Production
NCT00719160
Ultrasound Study of the Uterine Healing Process After Cesarean Delivery
NCT00224250
Low-Dose Naltrexone Combined With Bupropion to Stop Smoking With Less Weight Gain
NCT00129246
Effects of Sleep Loss on Endothelial Function and Cytokine Levels in Internal Medicine Residents
NCT00272233
Maximizing the Efficacy of Cognitive Behavior Therapy and Contingency Management
NCT00350649
Diagnosis and Treatment of Sleep-Disordered Breathing in the Homes of Patients With Transient Ischemic Attack
NCT00251290
Brief Interventions for Drop-out Re-engagement
NCT00350571
Continuous Positive Airway Pressure for the Treatment of Stroke
NCT00368628
What is open in the Yale University pipeline
254 recruiting of 1,492 indexed (17% open); 1,005 completed (67%).
Phase mix: 99 late (III/IV) vs 579 early (I/II) (early-phase heavy).
Top condition: Opioid Use Disorder (19 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Yale University: open-pipeline peers nationwide
Peers matched on 1,492 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Yale University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,492 trials (± recruiting share)
- Washington University School of Medicine · 1,502 trials · 14% recruiting
- Johns Hopkins University · 1,448 trials · 17% recruiting
- University of Pennsylvania · 1,423 trials · 14% recruiting
- Novartis Pharmaceuticals · 1,375 trials · 8% recruiting
Sponsors near 17% open enrollment (± trial volume)
- NYU Langone Health · 17% recruiting · 1,164 trials
- CSL Behring · 17% recruiting · 71 trials
- Penn State University · 17% recruiting · 219 trials
- University of Hawaii · 17% recruiting · 77 trials
Related
What to do with this Yale University page
1,492 registered trials is a research-attention snapshot, not an endorsement of Yale University or any single study.
- 254 of Yale University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Opioid Use Disorder is the condition Yale University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Opioid Use Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Yale University pipeline card: 1,492 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.